Dual vs Triple Anti-Thrombotic Therapy for Post-PCI Patients With Atrial Fibrillation

Published: 21 May 2020

  • Views:

    Views Icon 101
  • Likes:

    Heart Icon 0

Overview

Full programme

  • Views:

    Views Icon 101
  • Likes:

    Heart Icon 0

Overview

Learning Objectives

  • Discuss and debate the four major trials in the DOAC space for post PCI patients with atrial fibrillation in light of international guidelines
  • Review the differences in the study designs and aspirin cut-offs and the implications on the data
  • Discuss and analyse the role of aspirin in the treatment of anti-thrombotic post PCI for patients with Atrial Fibrillation and ACS
  • Analyse and debate the impact on patient care
This video series was funded by an unrestricted educational service from Boehringer Ingelheim.

Series overview

Part 1

Scope of the Problem and Key Challenges

1 session

  • Scope of the Problem and Key Challenges

    Watch now

Part 2

Evolution of the Data – the Trials and the Differences

1 session

  • Evolution of the Data – the Trials and the Differences

    Watch now

Part 3

Practical Implementation and Current Guidelines

1 session

  • Practical Implementation and Current Guidelines

    Watch now

Faculty biographies